Literature DB >> 15107849

Functional variants of OCTN cation transporter genes are associated with Crohn disease.

Vanya D Peltekova1, Richard F Wintle, Laurence A Rubin, Christopher I Amos, Qiqing Huang, Xiangjun Gu, Bill Newman, Mark Van Oene, David Cescon, Gordon Greenberg, Anne M Griffiths, Peter H St George-Hyslop, Katherine A Siminovitch.   

Abstract

Crohn disease is a chronic, inflammatory disease of the gastrointestinal tract. A locus of approximately 250 kb at 5q31 (IBD5) was previously associated with susceptibility to Crohn disease, as indicated by increased prevalence of a risk haplotype of 11 single-nucleotide polymorphisms among individuals with Crohn disease, but the pathogenic lesion in the region has not yet been identified. We report here that two variants in the organic cation transporter cluster at 5q31 (a missense substitution in SLC22A4 and a G-->C transversion in the SLC22A5 promoter) form a haplotype associated with susceptibility to Crohn disease. These variants alter transcription and transporter functions of the organic cation transporters and interact with variants in another gene associated with Crohn disease, CARD15, to increase risk of Crohn disease. These results suggest that SLC22A4, SLC22A5 and CARD15 act in a common pathogenic pathway to cause Crohn disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15107849     DOI: 10.1038/ng1339

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  204 in total

1.  Contribution of the IBD5 locus to inflammatory bowel disease: a meta-analysis.

Authors:  Jian Wang; Xi Wang; Hong Yang; Dong Wu; Li Wang; Jiaming Qian
Journal:  Hum Genet       Date:  2011-01-30       Impact factor: 4.132

2.  Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease.

Authors:  Yukihide Momozawa; Myriam Mni; Kayo Nakamura; Wouter Coppieters; Sven Almer; Leila Amininejad; Isabelle Cleynen; Jean-Frédéric Colombel; Peter de Rijk; Olivier Dewit; Yigael Finkel; Miquel A Gassull; Dirk Goossens; Debby Laukens; Marc Lémann; Cécile Libioulle; Colm O'Morain; Catherine Reenaers; Paul Rutgeerts; Curt Tysk; Diana Zelenika; Mark Lathrop; Jurgen Del-Favero; Jean-Pierre Hugot; Martine de Vos; Denis Franchimont; Severine Vermeire; Edouard Louis; Michel Georges
Journal:  Nat Genet       Date:  2010-12-12       Impact factor: 38.330

Review 3.  Genes and environment: how will our concepts on the pathophysiology of IBD develop in the future?

Authors:  Arthur Kaser; Sebastian Zeissig; Richard S Blumberg
Journal:  Dig Dis       Date:  2010-09-30       Impact factor: 2.404

Review 4.  Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models.

Authors:  Aya M Westbrook; Akos Szakmary; Robert H Schiestl
Journal:  Mutat Res       Date:  2010-03-16       Impact factor: 2.433

5.  Cytokine regulation of OCTN2 expression and activity in small and large intestine.

Authors:  Mikihiro Fujiya; Yuhei Inaba; Mark W Musch; Shien Hu; Yutaka Kohgo; Eugene B Chang
Journal:  Inflamm Bowel Dis       Date:  2010-08-18       Impact factor: 5.325

6.  L-carnitine, a diet component and organic cation transporter OCTN ligand, displays immunosuppressive properties and abrogates intestinal inflammation.

Authors:  G Fortin; K Yurchenko; C Collette; M Rubio; A-C Villani; A Bitton; M Sarfati; D Franchimont
Journal:  Clin Exp Immunol       Date:  2009-01-23       Impact factor: 4.330

Review 7.  Understanding the pathogenesis of psoriasis, psoriatic arthritis, and autoimmunity via a fusion of molecular genetics and immunology.

Authors:  Anne M Bowcock
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

8.  IBD5 polymorphisms in inflammatory bowel disease: association with response to infliximab.

Authors:  Elena Urcelay; Juan-Luis Mendoza; Alfonso Martinez; Laura Fernandez; Carlos Taxonera; Manuel Diaz-Rubio; Emilio-G de la Concha
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

9.  Genetic association of nonsynonymous variants of the IL23R with familial and sporadic inflammatory bowel disease in women.

Authors:  Zhenwu Lin; Lisa Poritz; Andre Franke; Tong-Yi Li; Andreas Ruether; Kathryn A Byrnes; Yunhua Wang; Anthony W Gebhard; Colin MacNeill; Neal J Thomas; Stefan Schreiber; Walter A Koltun
Journal:  Dig Dis Sci       Date:  2009-03-18       Impact factor: 3.199

10.  Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5).

Authors:  Harunobu Tahara; Sook Wah Yee; Thomas J Urban; Stephanie Hesselson; Richard A Castro; Michiko Kawamoto; Doug Stryke; Susan J Johns; Thomas E Ferrin; Pui-Yan Kwok; Kathleen M Giacomini
Journal:  J Pharmacol Exp Ther       Date:  2009-01-13       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.